Insulin began saving lives a century ago. Why is it still so unaffordable?

Jan 28, 2022
In other developed countries, affordability is far less of an issue.
One in four diabetics has rationed insulin because of its cost.
Photo illustration: Julia Schiff/Marketplace. Photo: Kerem Yucel/AFP via Getty Images

Here's why Eli Lilly will sell a generic insulin

Mar 4, 2019
Lawmakers have been critical of big pharma's pricing structures.

Drugmakers of insulin accused of price fixing

Jan 31, 2017
Three of the biggest makers of diabetes treatments have been accused of price fixing. A lawsuit filed this week claims that Sanofi, Novo Nordisk and Eli Lilly have been conspiring to drive up prices of insulin at the expense of their patients. Because of the high prices, the suit says some patients have been using […]